Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

154 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Caffeine, mental health, and psychiatric disorders.
Lara DR. Lara DR. J Alzheimers Dis. 2010;20 Suppl 1:S239-48. doi: 10.3233/JAD-2010-1378. J Alzheimers Dis. 2010. PMID: 20164571 Review.
Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
Dall'Igna OP, Da Silva AL, Dietrich MO, Hoffmann A, de Oliveira RV, Souza DO, Lara DR. Dall'Igna OP, et al. Psychopharmacology (Berl). 2003 Mar;166(3):258-63. doi: 10.1007/s00213-002-1362-1. Epub 2003 Feb 13. Psychopharmacology (Berl). 2003. PMID: 12589526
Effect of riluzole on MK-801 and amphetamine-induced hyperlocomotion.
Lourenço Da Silva A, Hoffmann A, Dietrich MO, Dall'Igna OP, Souza DO, Lara DR. Lourenço Da Silva A, et al. Neuropsychobiology. 2003;48(1):27-30. doi: 10.1159/000071825. Neuropsychobiology. 2003. PMID: 12886037
Caffeine as a neuroprotective adenosine receptor antagonist.
Dall'Igna OP, Souza DO, Lara DR. Dall'Igna OP, et al. Ann Pharmacother. 2004 Apr;38(4):717-8. doi: 10.1345/aph.1D307. Epub 2004 Feb 24. Ann Pharmacother. 2004. PMID: 14982979 No abstract available.
154 results
Jump to page
Feedback